International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease

Author(s): McElhiney Linda F

Issue: May/Jun 2012 - Volume 16, Number 3
View All Articles in Issue

Page(s): 190-195

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 1

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 2

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 3

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 4

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 5

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Page 6

Download in electronic PDF format for $75

Abstract: Vital dyes have been used for over a hundred years to assist ophthalmic practitioners in diagnosing their patients’ problems. Patients don’t always tolerate the commercial products, usually due to the preservatives, and may need a compounded preparation. Some dyes are not commercially available, such as the brilliant blue G, and compounders who specialize in high-risk compounded sterile preparations are needed to meet these needs of the ophthalmologists. This article discusses some of these staining agents, including their properties.

Related Keywords: Linda F. McElhiney, PharmD, RPh, FIACP, FASHP, FACA, vital dyes, ophthalmic stains, ocular pathology, eye disorders, formulations, cornea lesions, corneal abrasions, keratitis, preservatives, compounded sterile preparations, microbial contamination, ophthalmic solutions, fluorescein, rose bengal, dry eye, keratoconjunctivitis sicca, lissamine green B, brilliant blue G, intravitreal administration

Related Categories: FORMULATIONS, OPHTHALMICS, STERILE PREPARATIONS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease McElhiney Linda F	May/Jun 2012 Pg. 190-195
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis Mixon William, Angelle Patricea (Patsy), Chang Richard I	Nov/Dec 2009 Pg. 506-515
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Allen Loyd V Jr	Sep/Oct 2016 Pg. 399-404
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Allen Loyd V Jr	Nov/Dec 2016 Pg. 495-500
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2 Davidson Gigi S	Jul/Aug 2004 Pg. 277-283
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3 Davidson Gigi S	Sep/Oct 2004 Pg. 359-367
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Allen Loyd V Jr	Sep/Oct 2010 Pg. 421
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1 Davidson Gigi S	May/Jun 2004 Pg. 169-172
Prevention Is the Best Medicine: Don J. Bottoni, RPh, FACA, FIACP Bottoni Don J	Jan/Feb 2004 Pg. 22-27
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together McElhiney Linda F	Jul/Aug 2010 Pg. 270-274
Compounding for Feline Herpetic Keratitis Davidson Gigi S	Nov/Dec 2006 Pg. 411-414
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution McLellan Christine, Ngo Van, Pasedis Sophia, Dohlman Claes H	Sep/Oct 2008 Pg. 456-459
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R	Jan/Feb 2010 Pg. 40-45
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops Reed-Kane Dana, Carlson Rachel A, Kupiec Thomas C, Vu Nicole	Nov/Dec 2009 Pg. 540-543
Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension Davidson Michael G	Mar/Apr 2001 Pg. 92-94
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H	Sep/Oct 2014 Pg. 418-426
Atropine Sulfate 1% Ophthalmic Solution Allen Loyd V Jr	May/Jun 2015 Pg. 242
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Allen Loyd V Jr	Nov/Dec 2015 Pg. 508
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment Allen Loyd V Jr	Jan/Feb 2016 Pg. 51
Return to Top